Medicine overcharging claims are raising concerns about price controls in India.
Cancer drug prices are set to fall by up to 70% thanks to NPPA’s new trade margin caps.
Cancer drug price caps are reshaping investment strategies. Discover why Jefferies favors Fortis, Apollo, and Manipal amidst scrutiny.
Lilly Mounjaro Zepbound highlights the worst entry points in pharma approvals and their proven impact on the market.
Medical device price cap is essential for affordable healthcare and transparency.
Pharma revenue growth is projected at 11-13% as exports expand beyond the US.
Compass psychedelic drug launch is paving the way for new treatments in mental health.
IV set price caps are under scrutiny by Maharashtra FDA for fairness in pricing.